Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Medix - (AMEX: MXR) -- Ignore unavailable to you. Want to Upgrade?

To: scott_jiminez who wrote (219)	2/18/2001 11:59:09 AM
From: REH	Read Replies (1) \| Respond to of 226

If this was a planned event then why was no replacement named? This company has what I believe to be great core technology, especially in its UI-patent, but they have failed to raise necessary financing or revenue generating contracts (apart from Loyola which according to management is now revenue-generating - not significant enough for a PR it seems). We need smart money to invest in this company for it to be able to profit from its technology. Such smart money could come from Wellpoint (WLP) exercising their option for 1M shares at $ 0.30 or from the external BOD-members or from a serious financial or industry player. We have been plagued by too many rumors that have failed to materialize and time has run out on present leadership IMHO. It is BAD NEWS when the CTO leaves without any replacements (with solid CV) named as temporary or permanent replacement. Pfeil was not only CTO but also President and COO of the operating company: Cymedix. reh